I-View 2.0 Contrast Enhanced Mammography (CEM) technology is an alternative to breast MRI that provides equivalent diagnostic performance.1,2 The technology acquires a pair of high- and low-energy images in rapid succession to eliminate the structural background, and display regions of abnormal blood flow. Patients report preferring CEM over breast MRI thanks to its faster procedure time, greater comfort and lower noise level.3 The technology can easily be added to any Selenia Dimensions or 3Dimensions mammography system, allowing clinicians to expand their contrast capabilities using existing mammography equipment. When I-View 2.0 Contrast Enhanced Mammography is paired with Affirm Contrast Biopsy software, the technologies allow clinicians to target and acquire tissue samples in lesions identified with CEM where a correlate may not be found on a FFDM, DBT or ultrasound image. The contrast agents used are the same as the ones commonly used in standard CT examinations.
REFERENCES
- Chou C, Lewin J, Chiang C et al. “Clinical Evaluation of Contrast-Enhanced Digital Mammography and Contrast Enhanced Tomosynthesis-Comparison to Contrast-Enhanced Breast MRI” Eur J Radiol. 2015 Dec; 84(12):2501-8. [Epub 2015 Oct 1].
- Jochelson M, Dershaw D, Sung J, et al., Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma, Radiology 266 (3) (2013) 743–751
- Hobbes M, Taylor D, Buzynski S et al. “Contrast-enhanced spectral mammography (CESM) and contrast enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preference and tolerance” J Med Imaging Radiat Oncol. 2015 Jun;59(3):300-5. [Epub 2015 Apr 21].
